According to reports, Padmaavat has collected Rs 32 crore on its second day in the Indian markets. After much back and forth on the release date, the Ranveer Singh, Deepika Padukone, and Shahid Kapoor starrer opening to mixed reactions with certain sections of the audience flocking theatres, while in other territories the film failed to secure a single show due to protests. While the film is expected to create new benchmarks at the box office, do you think it will cross the Rs 200 crore mark?
Sanjay Leela Bhansali's directorial epic Padmaavat has turned out to be one of the most awaited films of all time in the history of Hindi cinema especially because of the controversy around it. The film had a great start in worldwide markets as the Ranveer-Deepika starrer raked in good numbers in Australia, New Zealand and the UK. "Had it been a smooth release (some states are not screening the film), the all-India business would've touched Rs 40 crore", Taran Adash said.
The film had gathered Rs 19 crore on Thursday and Rs 5 crore from the paid reviews that occurred on Wednesday. Rajasthan, Haryana, Gujarat and Madhya Pradesh state governments had also installed a ban on the film until the Supreme Court called it illegal in a ruling.
WH Funds Draft Ends Area Station Funding by 2025
The White House plans to end NASA's funding for ISS by 2025, according to a draft 2019 budget proposal seen by the Verge . Companies like SpaceX, Orbital ATK and Sierra Nevada Corp are paid billions to fly cargo and supplies there.
Padmaavat has managed to cross the box office collection record of Akshay Kumar's Toilet-Ek Prem Katha and Varun Dhawan starrer Judwaa 2, which minted Rs 30.2 crore and Rs 36.65 crore, respectively, in two days. "That is in a way the best response we can give, through the work that we do", said Deepika.
The movie is directed by Sanjay Leela Bhansali.
Well, the whole country knows that the movie came on the screens after too many controversies and protests by the Karni Sena over the alleged distortion of facts in the movie.